Moderna extends gains

No person-to-person spread has been detected, but that doesn’t mean an H5N1 avian influenza pandemic isn’t possible or even ...
Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an ...
As of market close on Friday, Jan. 24, Moderna stock is up 21.6% this week. Here's why.
Moderna wins EU tender to supply COVID-19 vaccines for up to four years, offering diverse formats like prefilled syringes to ...
Norovirus cases are significantly increasing in the US and Canada. Moderna is developing an mRNA-based vaccine, currently in ...
Moderna provided an update on the status of its trial investigating a vaccine candidate for norovirus in a company statement on Monday.
Cases of norovirus infections are surging, but coming up with a way to prevent them has proven to be a challenge.
Moderna cut its 2025 sales forecast by $1 billion on Monday, hurt by a slow adoption of its respiratory syncytial virus (RSV) ...
The misery of the common stomach flu may be coming to an end. Pharmaceutical company Moderna has launched a large-scale Phase ...